Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in managing hyperlipidaemia.

D Colquhoun1

  • 1University of Queensland.

Australian Family Physician
|April 29, 2000
PubMed
Summary
This summary is machine-generated.

Managing high cholesterol is crucial for preventing coronary artery disease. Current guidelines emphasize personalized cardiovascular risk assessment, considering diet and medication adherence for effective lipid management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

John Henry Gaddum's 1940 guidance on controlled clinical trials.

Journal of the Royal Society of Medicine·2019
Same author

Celebrating 1500 issues: preface to the first Journal.

The New Zealand medical journal·2019
Same author

Environmental biofilm communities associated with early-stage common dentex (Dentex dentex) culture.

Journal of applied microbiology·2019
Same author

Atlantic salmon bath challenged with Moritella viscosa--pathogen invasion and host response.

Fish & shellfish immunology·2009
Same author

Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.

Neurology·2009
Same author

Real-time PCR detection of Moritella viscosa, the likely causal agent of winter-ulcer in Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss.

Diseases of aquatic organisms·2009
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Preventive Cardiology

Background:

  • Elevated plasma cholesterol is a major modifiable risk factor for coronary artery disease, established by the Framingham study.
  • Recent research, including the Australian LIPID study, has refined acceptable cholesterol level guidelines.
  • Understanding cholesterol's role is key in cardiovascular health management.

Purpose of the Study:

  • To explore the significance of serum cholesterol levels in cardiovascular risk.
  • To discuss the impact of dietary modifications on lipid profiles.
  • To evaluate the role of lipid-lowering drug treatments in managing cardiovascular risk.

Main Methods:

  • Literature review of key studies (Framingham, LIPID).
  • Analysis of current challenges in lipid management.

Related Experiment Videos

  • Discussion of treatment individualization based on overall cardiovascular risk.

    • Main Results:

    • Serum cholesterol levels are a critical factor in cardiovascular risk.
    • Dietary modifications offer cardioprotective benefits beyond cholesterol reduction.
    • Some lipid-lowering treatments may also provide cardiovascular protection independently.

    Conclusions:

    • Key challenges in lipid management include medication adherence and determining target cholesterol levels.
    • Patient treatment decisions must integrate serum cholesterol with overall cardiovascular risk assessment.
    • Diet and certain lipid-lowering therapies possess cardioprotective effects independent of cholesterol modification.